Van Zant G, Thompson B P, Chen J J
Department of Cell Biology and Anatomy, Texas Tech University Health Sciences Center, Lubbock 79430.
Exp Hematol. 1991 Oct;19(9):941-9.
Bone marrow transplantation is of increasing utility in cancer treatment and is an important component of gene therapy protocols. Understanding the functional identities of progenitor cells involved in repopulation is important for the optimal application of this procedure. We have simultaneously used two types of genetic markers to study engraftment of mice after irradiation. The first involves intrinsic genetic differences, including a cellular marker, between two mouse strains used to construct chimeric mice by aggregating embryos. To produce a second marking system, bone marrow from these allophenic mice was subsequently infected with retrovirus. Individual progenitor cells, including primitive lympho-hematopoietic stem cells, participating in repopulation were identified by virtue of their uniquely marked clonal progeny. In this way numbers and genotypic identities of clones contributing to repopulation were determined. Engraftment could be divided into two distinguishable temporal phases. The first comprised roughly the first 3-4 months following transplant and was characterized by numerous clones, many of which apparently had limited lineage potencies. The subsequent phase was characterized by few, often a single, clones represented in all lympho-hematopoietic tissues. These findings are consistent with the notion that different classes of progenitor cells are differentially responsible for temporal progression. More differentiated, perhaps lineage restricted, progenitors transiently dominate the first few months before the emergence of pluripotent stem cell clones. Senescence of progenitors of the first phase may reflect their limited lifespans. A clear genotypic difference was obvious in engraftment. Cells of one strain, DBA/2, completely dominated the first temporal phase, whereas the C57BL/6 partner strain dominated the second phase. The genotype-restricted dominance of different stages of repopulation suggests important differences in the organization and regulation of stem and progenitor cell populations. Inherent differences in seeding, proliferation, and differentiation of progenitors of the two inbred strains may account for the differences. This in vivo model of competitive repopulation provides the opportunity to explore potentially important loci in the process of engraftment. We propose that DBA/2 progenitor cells, due to a proliferative and/or numerical advantage, account for their superiority immediately after engraftment. C57BL/6 stem cells, with long-term repopulating potential, predominate later, perhaps because of subtle numerical or proliferative advantages.
骨髓移植在癌症治疗中的应用日益广泛,是基因治疗方案的重要组成部分。了解参与再增殖的祖细胞的功能特性对于该程序的最佳应用至关重要。我们同时使用两种类型的遗传标记来研究照射后小鼠的植入情况。第一种涉及内在的遗传差异,包括细胞标记,这两种小鼠品系用于通过聚合胚胎构建嵌合小鼠。为了产生第二种标记系统,这些异基因小鼠的骨髓随后被逆转录病毒感染。通过其独特标记的克隆后代鉴定参与再增殖的单个祖细胞,包括原始淋巴造血干细胞。通过这种方式,确定了参与再增殖的克隆的数量和基因型特性。植入可分为两个可区分的时间阶段。第一个阶段大致包括移植后的前3 - 4个月,其特征是有许多克隆,其中许多显然具有有限的谱系潜能。随后的阶段特征是在所有淋巴造血组织中很少有克隆,通常是单个克隆。这些发现与不同类别的祖细胞对时间进程有不同责任的观点一致。更分化的、可能谱系受限的祖细胞在多能干细胞克隆出现之前的最初几个月短暂占主导地位。第一阶段祖细胞的衰老可能反映了它们有限的寿命。植入中明显存在明显的基因型差异。一个品系DBA/2的细胞在第一个时间阶段完全占主导地位,而C57BL/6伙伴品系在第二个阶段占主导地位。再增殖不同阶段的基因型受限优势表明干细胞和祖细胞群体的组织和调节存在重要差异。两个近交系祖细胞在播种、增殖和分化方面的固有差异可能解释了这些差异。这种体内竞争性再增殖模型为探索植入过程中潜在的重要基因座提供了机会。我们提出,DBA/2祖细胞由于增殖和/或数量优势,在植入后立即表现出优势。具有长期再增殖潜力的C57BL/6干细胞后来占主导地位,可能是由于细微的数量或增殖优势。